Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Zhou, Yujie"" wg kryterium: Autor


Tytuł :
Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty.
Autorzy :
Ge H; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China.
Zhou Y
Liu X
Nie X
Wang Z
Guo Y
Chen W
Yang Q
Pokaż więcej
Źródło :
Angiology [Angiology] 2012 Jan; Vol. 63 (1), pp. 62-6. Date of Electronic Publication: 2011 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Angioplasty, Balloon, Coronary*
Drug Resistance*
Acute Coronary Syndrome/*blood
Platelet Aggregation/*physiology
Platelet Aggregation Inhibitors/*pharmacology
Ticlopidine/*analogs & derivatives
Acute Coronary Syndrome/pathology ; Acute Coronary Syndrome/therapy ; Adult ; Blood Vessel Prosthesis Implantation ; C-Reactive Protein/metabolism ; CD40 Ligand/blood ; Clopidogrel ; Female ; Humans ; Interleukin-6/blood ; Male ; P-Selectin/blood ; Stents ; Ticlopidine/pharmacology ; Time Factors
Czasopismo naukowe
Tytuł :
Role of stromal cell-derived factor-1 in patients with non-ST elevation acute coronary syndrome.
Autorzy :
Tong G; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University.
Wang N
Zhou Y
Leng J
Gao W
Tong X
Shen Y
Yang J
Ye X
Zhou L
Gao Y
Pokaż więcej
Źródło :
International heart journal [Int Heart J] 2014; Vol. 55 (3), pp. 219-27. Date of Electronic Publication: 2014 May 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Electrocardiography*
Ventricular Remodeling*
Acute Coronary Syndrome/*blood
Chemokine CXCL12/*blood
Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/physiopathology ; Aged ; Biomarkers/blood ; Echocardiography ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; ROC Curve ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
Autorzy :
Ji Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China ; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Zeng Q; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Huang Y; Department of Ultrasound, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Shi Y; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Lin Y; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Lu Z; Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Meng K; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu B; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yu K; Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chai M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
Mediators of inflammation [Mediators Inflamm] 2014; Vol. 2014, pp. 165742. Date of Electronic Publication: 2014 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Coronary Syndrome/*blood
Intercellular Signaling Peptides and Proteins/*blood
Interleukin-1/*blood
Interleukin-18/*blood
Acute Disease ; Aged ; Angina Pectoris/blood ; C-Reactive Protein/metabolism ; Coronary Angiography ; Echocardiography, Doppler ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Leukocytes, Mononuclear/cytology ; Male ; Middle Aged ; Myocardial Infarction/blood ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Ventricular Function, Left
Czasopismo naukowe
Tytuł :
Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention.
Autorzy :
Bu C; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Zhao Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Ma H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Han H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Yang S; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Shi D; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Liu Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Fang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Wang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Ma Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Hu B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Yang Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Li Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Liu R; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Nie B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China.
Zhou Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2014 Aug; Vol. 65 (7), pp. 590-5. Date of Electronic Publication: 2013 Aug 28.
Typ publikacji :
Journal Article
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/methods
Acute Coronary Syndrome/*drug therapy
Acute Coronary Syndrome/*prevention & control
Cholesterol, LDL/*metabolism
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology
Aged ; Aged, 80 and over ; Aging ; Biomarkers/blood ; C-Reactive Protein/metabolism ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris.
Autorzy :
Ji Q
Lin Y
Liang Z
Yu K
Liu Y
Fang Z
Liu L
Shi Y
Zeng Q
Chang C
Chai M
Zhou Y
Pokaż więcej
Źródło :
Cardiovascular diabetology [Cardiovasc Diabetol] 2014 Nov 01; Vol. 13, pp. 145. Date of Electronic Publication: 2014 Nov 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Coronary Syndrome/*blood
Chemokines/*blood
Adiponectin/blood ; Adult ; Aged ; Aged, 80 and over ; Angina, Stable/blood ; Biomarkers/blood ; Female ; Humans ; Intercellular Signaling Peptides and Proteins ; Male ; Middle Aged ; Myocardial Infarction/blood
Czasopismo naukowe
Tytuł :
High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials.
Autorzy :
Wang L; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Peng P; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhang O; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Xu X; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Yang S; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhao Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Zhou Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2014 Dec 04; Vol. 9 (12), pp. e113352. Date of Electronic Publication: 2014 Dec 04 (Print Publication: 2014).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Elective Surgical Procedures*
Acute Coronary Syndrome/*drug therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage
Myocardial Infarction/*drug therapy
Acute Coronary Syndrome/epidemiology ; Acute Coronary Syndrome/surgery ; Humans ; Myocardial Infarction/epidemiology ; Myocardial Infarction/surgery ; Percutaneous Coronary Intervention/methods ; PubMed ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
Autorzy :
Yang Q; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Wang Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Hao Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Smith SC Jr; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Huo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Fonarow GC; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Ma C; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Ge J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Taubert KA; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Morgan L; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Guo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Wang W; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Zhou Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.).
Zhao D; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). .
Pokaż więcej
Corporate Authors :
CCC-ACS Investigators
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2017 Jun; Vol. 10 (6).
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Percutaneous Coronary Intervention*/standards
Acute Coronary Syndrome/*therapy
Anticoagulants/*administration & dosage
Fibrinolytic Agents/*administration & dosage
Non-ST Elevated Myocardial Infarction/*therapy
Platelet Aggregation Inhibitors/*administration & dosage
Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/diagnosis ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; China ; Clinical Decision-Making ; Coronary Angiography ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Fibrinolytic Agents/adverse effects ; Guideline Adherence ; Humans ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/blood ; Non-ST Elevated Myocardial Infarction/diagnosis ; Platelet Aggregation Inhibitors/adverse effects ; Practice Guidelines as Topic ; Practice Patterns, Physicians' ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Time-to-Treatment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The impact of acute coronary syndrome on late drug-eluting stents restenosis: Insights from optical coherence tomography.
Autorzy :
Wu S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Department of Cardiology, China National Petroleum Corporation Central Hospital, Langfang, PR China.
Liu W
Guo Y
Zeng Y
Zhou Z
Zhao Y
Liu Y
Shi D
Wang Z
Ge H
Wang J
Jin P
Zhou Y
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2017 Dec; Vol. 96 (52), pp. e9515.
Typ publikacji :
Journal Article
MeSH Terms :
Drug-Eluting Stents*
Acute Coronary Syndrome/*pathology
Acute Coronary Syndrome/diagnostic imaging ; Aged ; Angina, Stable/diagnostic imaging ; Angina, Stable/pathology ; Constriction, Pathologic ; Female ; Humans ; Male ; Middle Aged ; Neointima/pathology ; Retrospective Studies ; Thrombosis/pathology ; Tomography, Optical Coherence
Czasopismo naukowe
Tytuł :
Very High Serum Uric Acid Levels, Plaque Morphology, and the Acute Coronary Syndrome.
Autorzy :
Lv S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Diseases, Clinical Center for Coronary Heart Diseases, Beijing, China.
Ohene BE; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Diseases, Clinical Center for Coronary Heart Diseases, Beijing, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Diseases, Clinical Center for Coronary Heart Diseases, Beijing, China, .
Pokaż więcej
Źródło :
Cardiology [Cardiology] 2018; Vol. 141 (4), pp. 199-201. Date of Electronic Publication: 2019 Feb 13.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Acute Coronary Syndrome*
Coronary Artery Disease*
Plaque, Atherosclerotic*
Humans ; Tomography, Optical Coherence ; Uric Acid
Opinia redakcyjna
Tytuł :
Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome.
Autorzy :
Lv S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Liu W; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. .
Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Zhao Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Alhelal JW; International School of Capital Medical University, Beijing, China.
Ravuru KSS; International School of Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
Cardiology journal [Cardiol J] 2019; Vol. 26 (3), pp. 275-282. Date of Electronic Publication: 2018 Mar 07.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Acute Coronary Syndrome/*epidemiology
Coronary Artery Disease/*epidemiology
Hyperuricemia/*epidemiology
Acute Coronary Syndrome/diagnostic imaging ; Adolescent ; Adult ; Age Factors ; Biomarkers/blood ; China/epidemiology ; Coronary Artery Disease/diagnostic imaging ; Female ; Humans ; Hyperuricemia/blood ; Hyperuricemia/diagnosis ; Incidence ; Male ; Risk Assessment ; Risk Factors ; Severity of Illness Index ; Uric Acid/blood ; Young Adult
Czasopismo naukowe
Tytuł :
Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.
Autorzy :
Xu K; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Fu G; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Xu B; State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Centre for Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Su X; Department of Cardiology, Wuhan Asia Heart Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
Liu H; Department of Cardiology, Chinese Armed Police Force General Hospital, Beijing, China.
Zhang Z; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Yu B; Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China.
Wang X; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Han Y; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Pokaż więcej
Corporate Authors :
NeoVas OPC Investigators
Źródło :
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Feb 15; Vol. 93 (S1), pp. 832-838.
Typ publikacji :
Journal Article
MeSH Terms :
Absorbable Implants*
Coated Materials, Biocompatible*
Acute Coronary Syndrome/*therapy
Cardiovascular Agents/*administration & dosage
Coronary Artery Disease/*therapy
Percutaneous Coronary Intervention/*instrumentation
Sirolimus/*administration & dosage
Acute Coronary Syndrome/diagnostic imaging ; Acute Coronary Syndrome/mortality ; Adolescent ; Adult ; Aged ; Cardiovascular Agents/adverse effects ; China ; Coronary Artery Disease/diagnostic imaging ; Coronary Artery Disease/mortality ; Female ; Humans ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/mortality ; Prospective Studies ; Prosthesis Design ; Randomized Controlled Trials as Topic ; Registries ; Risk Factors ; Sirolimus/adverse effects ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Gender-specific associations between atherogenic index of plasma and the presence and severity of acute coronary syndrome in very young adults: a hospital-based observational study.
Autorzy :
Cai G; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.; Department of Cardiology, Wujin Hospital affiliated with Jiangsu University, Changzhou, 213017, Jiangsu, China.
Liu W; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
Lv S; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
Wang X; Emergency & Critical Care Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
Guo Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
Yan Z; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
Du Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China.
Zhou Y; Department of Cardiology, 12th ward, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical center for coronary heart disease, Capital Medical University, Beijing, 100029, China. .
Pokaż więcej
Źródło :
Lipids in health and disease [Lipids Health Dis] 2019 Apr 13; Vol. 18 (1), pp. 99. Date of Electronic Publication: 2019 Apr 13.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Acute Coronary Syndrome/*blood
Angina, Unstable/*blood
Atherosclerosis/*blood
Myocardial Infarction/*blood
Acute Coronary Syndrome/diagnostic imaging ; Acute Coronary Syndrome/physiopathology ; Adult ; Age of Onset ; Angina, Unstable/diagnostic imaging ; Angina, Unstable/physiopathology ; Atherosclerosis/diagnostic imaging ; Atherosclerosis/physiopathology ; Case-Control Studies ; China ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Coronary Angiography ; Female ; Hospitals ; Humans ; Logistic Models ; Male ; Myocardial Infarction/diagnostic imaging ; Myocardial Infarction/physiopathology ; Risk Factors ; Severity of Illness Index ; Sex Factors ; Triglycerides/blood
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies